Neuroscience
From the FDA:
- Epilepsy News
A press release from the NIH: Ultrathin flexible brain implant offers unique look at seizures in NIH-funded research 13 November 2011 [snippet] Researchers funded by the National Institutes of Health have developed a flexible brain implant that could...
- Fda: Lundbeck's Sabril (vigabatrin) And Infantile Spasms
From a press release by the FDA: Sabril Approved by FDA to Treat Spasms in Infants and Epileptic Seizures Sabril (vigabatrin) Oral Solution has been approved by the U.S. Food and Drug Administration to treat infantile spasms in children ages 1 month to...
- Fda: Saphris (asenapine) Approval, Schizophrenia And Bipolar
From the FDA: FDA Approves Saphris to Treat Schizophrenia and Bipolar Disorder The U.S. Food and Drug Administration has approved Saphris tablets (asenapine) to treat adults with schizophrenia, a chronic, severe and disabling brain disorder, and to treat...
- Neuropsychology Abstract Of The Day: Epilepsy
Devinsky J. A diary of epilepsy in the early 1800s. Epilepsy and Behavior, 2007 Jan 29; [Epub ahead of print]. 97 Westview Road, Short Hills, NJ 07078, USA. This article describes the diary of a man from 19th-century England (1829-1834) that documents...
- Fda Approves Invega (paliperidone)
An FDA Press Release: FOR IMMEDIATE RELEASE P06-208 December 20, 2006 Media Inquiries: Press Office, 301-827-6242 Consumer Inquiries: 888-INFO-FDA FDA Approves New Drug for Schizophrenia The Food and Drug Administration (FDA) today approved Invega (paliperidone)...
Neuroscience
Epilepsy: FDA Approves Aptiom (eslicarbazepine acetate) to Treat Seizures in Adults
From the FDA:
FDA approves Aptiom to treat seizures in adults
08 November 2013
"The U.S. Food and Drug Administration today approved Aptiom (eslicarbazepine acetate) as an add-on medication to treat seizures associated with epilepsy."
Read the news release
- Epilepsy News
A press release from the NIH: Ultrathin flexible brain implant offers unique look at seizures in NIH-funded research 13 November 2011 [snippet] Researchers funded by the National Institutes of Health have developed a flexible brain implant that could...
- Fda: Lundbeck's Sabril (vigabatrin) And Infantile Spasms
From a press release by the FDA: Sabril Approved by FDA to Treat Spasms in Infants and Epileptic Seizures Sabril (vigabatrin) Oral Solution has been approved by the U.S. Food and Drug Administration to treat infantile spasms in children ages 1 month to...
- Fda: Saphris (asenapine) Approval, Schizophrenia And Bipolar
From the FDA: FDA Approves Saphris to Treat Schizophrenia and Bipolar Disorder The U.S. Food and Drug Administration has approved Saphris tablets (asenapine) to treat adults with schizophrenia, a chronic, severe and disabling brain disorder, and to treat...
- Neuropsychology Abstract Of The Day: Epilepsy
Devinsky J. A diary of epilepsy in the early 1800s. Epilepsy and Behavior, 2007 Jan 29; [Epub ahead of print]. 97 Westview Road, Short Hills, NJ 07078, USA. This article describes the diary of a man from 19th-century England (1829-1834) that documents...
- Fda Approves Invega (paliperidone)
An FDA Press Release: FOR IMMEDIATE RELEASE P06-208 December 20, 2006 Media Inquiries: Press Office, 301-827-6242 Consumer Inquiries: 888-INFO-FDA FDA Approves New Drug for Schizophrenia The Food and Drug Administration (FDA) today approved Invega (paliperidone)...